4574 — Taiko Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥17bn
- ¥15bn
- ¥6bn
- 21
- 11
- 57
- 15
2019 March 31st | 2020 March 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,986 | 3,504 | -8,887 | -4,869 | -3,563 |
Depreciation | |||||
Non-Cash Items | -162 | 339 | 2,972 | -33 | 2,348 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -536 | -846 | 3,378 | 2,172 | 204 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,748 | 3,493 | -1,596 | -1,993 | -307 |
Capital Expenditures | -506 | -220 | -1,600 | -84 | -114 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -241 | -228 | -22 | 274 | 1,280 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -747 | -448 | -1,622 | 190 | 1,166 |
Financing Cash Flow Items | — | — | -1 | -30 | 7 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -338 | -581 | 3,959 | -997 | 1,539 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 645 | 2,453 | 823 | -2,724 | 2,447 |